Sense and nonsense of pathway analysis software in proteomics.

New developments in proteomics enable scientists to examine hundreds to thousands of proteins in parallel. Quantitative proteomics allows the comparison of different proteomes of cells, tissues, or body fluids with each other. Analyzing and especially organizing these data sets is often a Herculean task. Pathway Analysis software tools aim to take over this task based on present knowledge. Companies promise that their algorithms help to understand the significance of scientist's data, but the benefit remains questionable, and a fundamental systematic evaluation of the potential of such tools has not been performed until now. Here, we tested the commercial Ingenuity Pathway Analysis tool as well as the freely available software STRING using a well-defined study design in regard to the applicability and value of their results for proteome studies. It was our goal to cover a wide range of scientific issues by simulating different established pathways including mitochondrial apoptosis, tau phosphorylation, and Insulin-, App-, and Wnt-signaling. Next to a general assessment and comparison of the pathway analysis tools, we provide recommendations for users as well as for software developers to improve the added value of a pathway study implementation in proteomic pipelines.

[1]  Peter Rossing,et al.  Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients , 2010, Clinical Proteomics.

[2]  C. Vulpe,et al.  Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins , 2008, Proteomics.

[3]  Lello Zolla,et al.  Human milk proteins: an interactomics and updated functional overview. , 2010, Journal of proteome research.

[4]  Mark Peifer,et al.  It takes more than two to tango: Dishevelled polymerization and Wnt signaling , 2007, Nature Structural &Molecular Biology.

[5]  Julian A. Hiscox,et al.  Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus subgroup B using SILAC coupled to LC‐MS/MS , 2010, Proteomics.

[6]  Jian Yu,et al.  PUMA, a potent killer with or without p53 , 2008, Oncogene.

[7]  Katrin Marcus,et al.  The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics—Relevance for Alzheimer's disease , 2008, Progress in Neurobiology.

[8]  Robert A Keyzers,et al.  The algal metabolite yessotoxin affects heterogeneous nuclear ribonucleoproteins in HepG2 cells , 2009, Proteomics.

[9]  Ying Zhang,et al.  Comparative Proteomics and Correlated Signaling Network of Rat Hippocampus in the Pilocarpine Model of Temporal Lobe Epilepsy , 2007 .

[10]  Bo Liu,et al.  Shotgun Proteomics and Network Analysis between Plasma Membrane and Extracellular Matrix Proteins from Rat Olfactory Ensheathing Cells , 2010, Cell transplantation.

[11]  Yingqi Hua,et al.  Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines , 2010, BMC Cancer.

[12]  E. Mandelkow,et al.  The tau of MARK: a polarized view of the cytoskeleton. , 2009, Trends in biochemical sciences.

[13]  C. Arce,et al.  Biological pathway analysis by ArrayUnlock and Ingenuity Pathway Analysis , 2009, BMC proceedings.

[14]  E. B. Wilson.  Probable Inference, the Law of Succession, and Statistical Inference , 1927 .

[15]  Ian R Whittle,et al.  Network generation enhances interpretation of proteomic data from induced apoptosis , 2010, Proteomics.

[16]  Shane C Burgess,et al.  Global liver proteomics of rats exposed for 5 days to phenobarbital identifies changes associated with cancer and with CYP metabolism. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  Yu Xi Zhang,et al.  Differential phosphoprotein levels and pathway analysis identify the transition mechanism of LNCaP cells into androgen‐independent cells , 2009, The Prostate.

[18]  Joachim Klose,et al.  Proteomic Shifts in Embryonic Stem Cells with Gene Dose Modifications Suggest the Presence of Balancer Proteins in Protein Regulatory Networks , 2007, PloS one.

[19]  G. Gourley,et al.  Proteomic Analysis of Biopsied Human Colonic Mucosa , 2010, Journal of pediatric gastroenterology and nutrition.

[20]  Allan R Brasier,et al.  Diabetes‐induced changes in the renal cortical proteome assessed with two‐dimensional gel electrophoresis and mass spectrometry , 2007, Proteomics.

[21]  Charlotte Schubert,et al.  Alterations in cerebral metabolomics and proteomic expression during sepsis. , 2007, Current neurovascular research.

[22]  S. Gaskell,et al.  Identification of early proteomic markers for hepatic steatosis. , 2006, Chemical research in toxicology.

[23]  E. Diamandis,et al.  Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer. , 2009, Journal of proteome research.

[24]  Martin Klammer,et al.  Identifying differentially regulated subnetworks from phosphoproteomic data , 2010, BMC Bioinformatics.

[25]  Chen Li,et al.  Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis , 2009, Electrophoresis.

[26]  K. Guan,et al.  Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? , 2006, Oncogene.

[27]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[28]  B. Kaina,et al.  DNA damage-induced cell death by apoptosis. , 2006, Trends in molecular medicine.

[29]  Paul C. Guest,et al.  Proteomic analysis identifies alterations in cellular morphology and cell death pathways in mouse brain after chronic corticosterone treatment , 2006, Brain Research.

[30]  Roger Bumgarner,et al.  Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome. , 2008, American journal of respiratory and critical care medicine.

[31]  K. Marcus,et al.  The AICD interacting protein DAB1 is up-regulated in Alzheimer frontal cortex brain samples and causes deregulation of proteins involved in gene expression changes. , 2011, Current Alzheimer research.

[32]  Lennart Martens,et al.  Automated reprocessing pipeline for searching heterogeneous mass spectrometric data of the HUPO Brain Proteome Project pilot phase , 2006, Proteomics.